Close

UPDATE - Barclays Downgraded Par Pharmaceutical (PRX) to Equalweight; Relative Risk/Reward Drives Rating Change Jan 6, 2011 03:20PM
Barclays Downgrades Par Pharmaceutical (PRX) to Equalweight Jan 6, 2011 11:30AM
Barclays on Specialty Pharmaceuticals: June Qtr Preview for Selected Companies Jul 16, 2010 12:58PM
Notable Analyst Rating Changes 10/15: JPM, PCG, NVLS, PRX Upgrade; BJS, BHI, SCHW, AZ, TRV, LAZ Downgrade Oct 15, 2009 10:44AM
Par Pharmaceuticals (PRX): Upgraded to Overweight at Barclays; target raised to $30 Oct 15, 2009 09:19AM


Oct 15, 2009 08:15AM Barclays Upgrades Par Pharmaceutical (PRX) to Overweight